Skip to main content
Top

01-03-2020 | Obesity | Original article

Predictive performance of lipid accumulation product and visceral adiposity index for renal function decline in non-diabetic adults, an 8.6-year follow-up

Published in: Clinical and Experimental Nephrology | Issue 3/2020

Login to get access

Abstract

Background

Lipid accumulation product (LAP) and visceral adiposity index (VAI) are surrogates for visceral adiposity dysfunction. Our aim was to evaluate potential association of these two indices with the incidence of renal function decline.

Methods

We included 6693 non-diabetic adults age ≥ 18 years, with estimated glomerular filtration rate (eGFR) ≥ 60 ml/min/1.73 m2, from the Tehran Lipid and Glucose Study 2002–2005 survey. Natural logarithmic transformation (Ln) was applied for LAP and VAI measures. The incidence of renal function decline, defined as eGFR < 60 ml/min/1.73 m2, was evaluated for each gender, across tertiles of Ln LAP, Ln VAI, body mass index (BMI), waist circumference (WC), waist to height ratio (WHtR) and waist to hip ratio (WHR), using Cox-proportional hazard models.

Results

Over a median 8.6 years of follow-up, 1670 new cases of renal function decline were identified (incidence rate 3.2%). After multivariable adjustment, the hazard ratios (HRs) with 95% CI across second and third tertiles of Ln LAP were 1.14 (0.86–1.50) and 1.33 (1.00–1.78) in men (P trend = 0.132); and 1.16 (0.90–1.50) and 1.24 (0.96–1.61) in women (P trend = 0.263), respectively. Multivariable adjusted HRs across second and third tertiles of Ln VAI were 1.40 (1.08–1.83) and 1.35 (1.02–1.78) in men (P trend = 0.031); and 0.93 (0.75–1.15) and 1.15 (0.93–1.41) in women (P trend = 0.072), respectively. HRs across tertiles of BMI, WC, WHtR and WHR were not significant for renal function decline among both genders in any adjustment models.

Conclusion

Among the adiposity indices assessed in this study, VAI seems to be an independent predictor of renal function decline only in males.
Literature
1.
go back to reference Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765.CrossRef Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765.CrossRef
2.
go back to reference Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034–47.CrossRef Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034–47.CrossRef
3.
go back to reference Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 2017;91(5):1224–35.CrossRef Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 2017;91(5):1224–35.CrossRef
4.
go back to reference Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, et al. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ. 2019;364:k5301.CrossRef Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, et al. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ. 2019;364:k5301.CrossRef
5.
go back to reference Tchernof A, Després J-P. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404.CrossRef Tchernof A, Després J-P. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404.CrossRef
6.
go back to reference Kim SR, Yoo JH, Song HC, Lee SS, Yoo SJ, Kim Y-D, et al. Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus. Nephrol Dial Transplant. 2010;26(11):3550–5.CrossRef Kim SR, Yoo JH, Song HC, Lee SS, Yoo SJ, Kim Y-D, et al. Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus. Nephrol Dial Transplant. 2010;26(11):3550–5.CrossRef
7.
go back to reference Alvehus M, Burén J, Sjöström M, Goedecke J, Olsson T. The human visceral fat depot has a unique inflammatory profile. Obesity. 2010;18(5):879–83.CrossRef Alvehus M, Burén J, Sjöström M, Goedecke J, Olsson T. The human visceral fat depot has a unique inflammatory profile. Obesity. 2010;18(5):879–83.CrossRef
8.
go back to reference Shuster A, Patlas M, Pinthus J, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85(1009):1–10.CrossRef Shuster A, Patlas M, Pinthus J, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85(1009):1–10.CrossRef
9.
go back to reference Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.CrossRef Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.CrossRef
10.
go back to reference Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disorders. 2005;5(1):26.CrossRef Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disorders. 2005;5(1):26.CrossRef
11.
go back to reference Ioachimescu AG, Brennan DM, Hoar BM, Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS Database Study. Obesity. 2010;18(9):1836–44.CrossRef Ioachimescu AG, Brennan DM, Hoar BM, Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS Database Study. Obesity. 2010;18(9):1836–44.CrossRef
12.
go back to reference Bozorgmanesh M, Hadaegh F, Azizi F. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis. 2010;9(1):45.CrossRef Bozorgmanesh M, Hadaegh F, Azizi F. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis. 2010;9(1):45.CrossRef
13.
go back to reference Kouli G-M, Panagiotakos DB, Kyrou I, Georgousopoulou EN, Chrysohoou C, Tsigos C, et al. Visceral adiposity index and 10-year cardiovascular disease incidence: the ATTICA study. Nutr Metab Cardiovasc Dis. 2017;27(10):881–9.CrossRef Kouli G-M, Panagiotakos DB, Kyrou I, Georgousopoulou EN, Chrysohoou C, Tsigos C, et al. Visceral adiposity index and 10-year cardiovascular disease incidence: the ATTICA study. Nutr Metab Cardiovasc Dis. 2017;27(10):881–9.CrossRef
14.
go back to reference Chen Y-C, Lai S-H, Tsai Y-W, Chang S-S. Visceral adiposity index as a predictor of chronic kidney disease in a relatively healthy population in Taiwan. J Renal Nutr. 2018;28(2):91–100.CrossRef Chen Y-C, Lai S-H, Tsai Y-W, Chang S-S. Visceral adiposity index as a predictor of chronic kidney disease in a relatively healthy population in Taiwan. J Renal Nutr. 2018;28(2):91–100.CrossRef
15.
go back to reference Dai D, Chang Y, Chen Y, Chen S, Yu S, Guo X, et al. Visceral adiposity index and lipid accumulation product index: two alternate body indices to identify chronic kidney disease among the rural population in Northeast China. Int J Environ Res Pub Health. 2016;13(12):1231.CrossRef Dai D, Chang Y, Chen Y, Chen S, Yu S, Guo X, et al. Visceral adiposity index and lipid accumulation product index: two alternate body indices to identify chronic kidney disease among the rural population in Northeast China. Int J Environ Res Pub Health. 2016;13(12):1231.CrossRef
16.
go back to reference Zhang K, Li Q, Chen Y, Wang N, Lu Y. Visceral adiposity and renal function: an observational study from SPECT-China. Lipids Health Dis. 2017;16(1):205.CrossRef Zhang K, Li Q, Chen Y, Wang N, Lu Y. Visceral adiposity and renal function: an observational study from SPECT-China. Lipids Health Dis. 2017;16(1):205.CrossRef
17.
go back to reference Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10(1):5.CrossRef Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10(1):5.CrossRef
18.
go back to reference Association AD. Standards of medical care in diabetes—2015 abridged for primary care providers. Clin Diabetes. 2015;33(2):97.CrossRef Association AD. Standards of medical care in diabetes—2015 abridged for primary care providers. Clin Diabetes. 2015;33(2):97.CrossRef
19.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRef Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRef
20.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.CrossRef Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.CrossRef
21.
go back to reference Expert Panel on Detection E. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486.CrossRef Expert Panel on Detection E. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486.CrossRef
23.
go back to reference Onat A, Avcı GŞ, Barlan M, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes. 2004;28(8):1018.CrossRef Onat A, Avcı GŞ, Barlan M, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes. 2004;28(8):1018.CrossRef
24.
go back to reference Oh H, Quan SA, Jeong J-Y, Jang S-N, Lee JE, Kim D-H. Waist circumference, not body mass index, is associated with renal function decline in korean population: hallym aging study. PLoS One. 2013;8(3):e59071.CrossRef Oh H, Quan SA, Jeong J-Y, Jang S-N, Lee JE, Kim D-H. Waist circumference, not body mass index, is associated with renal function decline in korean population: hallym aging study. PLoS One. 2013;8(3):e59071.CrossRef
25.
go back to reference Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis. 2008;52(1):29–38.CrossRef Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis. 2008;52(1):29–38.CrossRef
26.
go back to reference Odagiri K, Mizuta I, Yamamoto M, Miyazaki Y, Watanabe H, Uehara A. Waist to height ratio is an independent predictor for the incidence of chronic kidney disease. PLoS One. 2014;9(2):e88873.CrossRef Odagiri K, Mizuta I, Yamamoto M, Miyazaki Y, Watanabe H, Uehara A. Waist to height ratio is an independent predictor for the incidence of chronic kidney disease. PLoS One. 2014;9(2):e88873.CrossRef
27.
go back to reference Lemieux I, Pascot A, Couillard C, Lamarche BT, Tchernof A, Alméras N, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102(2):179–84.CrossRef Lemieux I, Pascot A, Couillard C, Lamarche BT, Tchernof A, Alméras N, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102(2):179–84.CrossRef
28.
go back to reference Ramezankhani A, Azizi F, Ghanbarian A, Parizadeh D, Hadaegh F. The hypertriglyceridemic waist and waist-to-height ratio phenotypes and chronic kidney disease: cross-sectional and prospective investigations. Obes Res Clin Pract. 2017;11(5):585–96.CrossRef Ramezankhani A, Azizi F, Ghanbarian A, Parizadeh D, Hadaegh F. The hypertriglyceridemic waist and waist-to-height ratio phenotypes and chronic kidney disease: cross-sectional and prospective investigations. Obes Res Clin Pract. 2017;11(5):585–96.CrossRef
29.
go back to reference Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D. Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care. 2005;28(10):2436–40.CrossRef Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D. Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care. 2005;28(10):2436–40.CrossRef
30.
go back to reference Jadhakhan F, Marshall T, Ryan R, Gill P. Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records. BMC Nephrol. 2018;19(1):42.CrossRef Jadhakhan F, Marshall T, Ryan R, Gill P. Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records. BMC Nephrol. 2018;19(1):42.CrossRef
31.
go back to reference Pscheidt C, Nagel G, Zitt E, Kramar R, Concin H, Lhotta K. Sex-and time-dependent patterns in risk factors of end-stage renal disease: a large Austrian cohort with up to 20 years of follow-up. PLoS One. 2015;10(8):e0135052.CrossRef Pscheidt C, Nagel G, Zitt E, Kramar R, Concin H, Lhotta K. Sex-and time-dependent patterns in risk factors of end-stage renal disease: a large Austrian cohort with up to 20 years of follow-up. PLoS One. 2015;10(8):e0135052.CrossRef
32.
go back to reference Wang X, Fan F, Jia J, Xu X, Qin X, Zheng B, et al. Association of different glucose traits with kidney function decline risk in a Chinese community-based population without chronic kidney disease. Ther Clin Risk Manag. 2018;14:1725.CrossRef Wang X, Fan F, Jia J, Xu X, Qin X, Zheng B, et al. Association of different glucose traits with kidney function decline risk in a Chinese community-based population without chronic kidney disease. Ther Clin Risk Manag. 2018;14:1725.CrossRef
33.
go back to reference Neamat-Allah J, Wald D, Hüsing A, Teucher B, Wendt A, Delorme S, et al. Validation of anthropometric indices of adiposity against whole-body magnetic resonance imaging—a study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) Cohorts. PLoS One. 2014;9(3):e91586.CrossRef Neamat-Allah J, Wald D, Hüsing A, Teucher B, Wendt A, Delorme S, et al. Validation of anthropometric indices of adiposity against whole-body magnetic resonance imaging—a study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) Cohorts. PLoS One. 2014;9(3):e91586.CrossRef
34.
go back to reference Pausova Z. From big fat cells to high blood pressure: a pathway to obesity-associated hypertension. Curr Opin Nephrol Hypertens. 2006;15(2):173–8.CrossRef Pausova Z. From big fat cells to high blood pressure: a pathway to obesity-associated hypertension. Curr Opin Nephrol Hypertens. 2006;15(2):173–8.CrossRef
36.
go back to reference Briffa JF, McAinch AJ, Poronnik P, Hryciw DH. Adipokines as a link between obesity and chronic kidney disease. Am J Physiol Renal Physiol. 2013;305(12):F1629–36.CrossRef Briffa JF, McAinch AJ, Poronnik P, Hryciw DH. Adipokines as a link between obesity and chronic kidney disease. Am J Physiol Renal Physiol. 2013;305(12):F1629–36.CrossRef
37.
go back to reference Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA. 2015;313(8):837–46.CrossRef Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA. 2015;313(8):837–46.CrossRef
Metadata
Title
Predictive performance of lipid accumulation product and visceral adiposity index for renal function decline in non-diabetic adults, an 8.6-year follow-up
Publication date
01-03-2020
Keywords
Obesity
Obesity
Published in
Clinical and Experimental Nephrology / Issue 3/2020
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-019-01813-7